Dashboard
Manage Tickers

INSM


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-maintains-buy-on-insmed-raises-price-target-to-194
UBS Maintains Buy on Insmed, Raises Price ...
10/14/2025 16:02:17

UBS analyst Trung Huynh maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $140 to $194.

heres-how-much-1000-invested-in-insmed-10-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Insmed 1...
10/07/2025 15:30:35

goldman-sachs-maintains-buy-on-insmed-raises-price-target-to-196
Goldman Sachs Maintains Buy on Insmed, Rai...
10/03/2025 16:59:31

Goldman Sachs analyst Andrea Tan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $121 to $196.

analyst-expectations-for-insmeds-future
Analyst Expectations For Insmed's Future
10/02/2025 18:00:52

td-cowen-maintains-buy-on-insmed-raises-price-target-to-193
TD Cowen Maintains Buy on Insmed, Raises P...
10/02/2025 14:06:47

TD Cowen analyst Ritu Baral maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $154 to $193.

6-stocks-goldman-sachs-says-are-poised-for-potential-acquisition-in-next-12-months--including-a-huge-200-winner
6 Stocks Goldman Sachs Says Are Poised For...
09/30/2025 13:11:43

Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year.

spotlight-on-insmed-analyzing-the-surge-in-options-activity
Spotlight on Insmed: Analyzing the Surge i...
09/25/2025 19:01:31

Financial giants have made a conspicuous bearish move on Insmed. Our analysis of options history for Insmed (NASDAQ: INSM) reve...

heres-how-much-100-invested-in-insmed-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Insmed 10...
09/22/2025 14:32:18

insmed-to-present-seven-abstracts-from-across-its-late-stage-portfolio-at-ers-2025-congress
Insmed To Present Seven Abstracts From Acr...
09/22/2025 11:13:04

—Data from Phase 2b Study of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Arterial Hypertension to be Pre...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
09/09/2025 17:35:29

guggenheim-maintains-buy-on-insmed-raises-price-target-to-172
Guggenheim Maintains Buy on Insmed, Raises...
09/08/2025 13:41:38

Guggenheim analyst Vamil Divan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $125 to $172.

deep-dive-into-insmed-stock-analyst-perspectives-26-ratings
Deep Dive Into Insmed Stock: Analyst Persp...
09/03/2025 19:01:05

wells-fargo-maintains-overweight-on-insmed-raises-price-target-to-171
Wells Fargo Maintains Overweight on Insmed...
09/03/2025 12:56:34

Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $140 to $171.

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

israel-englanders-millennium-goes-all-in-on-crypto-and-healthcare-while-rebalancing-big-tech-bets-bitcoin-etf-and-palantir-stakes-soar-in-q2
Israel Englander's Millennium Goes All-In ...
08/27/2025 07:07:43

Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalanc...

1000-invested-in-insmed-10-years-ago-would-be-worth-this-much-today
$1000 Invested In Insmed 10 Years Ago Woul...
08/21/2025 14:00:26

hewlett-packard-enterprise-to-rally-around-33-here-are-10-top-analyst-forecasts-for-thursday
Hewlett Packard Enterprise To Rally Around...
08/21/2025 12:19:31

morgan-stanley-maintains-equal-weight-on-insmed-raises-price-target-to-144
Morgan Stanley Maintains Equal-Weight on I...
08/21/2025 11:36:31

Morgan Stanley analyst Maxwell Skor maintains Insmed (NASDAQ:INSM) with a Equal-Weight and raises the price target from $126...

lung-disease-focused-insmed-must-own-name-for-investors
Lung Disease-Focused Insmed 'Must-Own' Nam...
08/20/2025 18:46:57

Insmed gains FDA approval for Brinsupri in bronchiectasis, while analysts see multi-billion sales potential from its expanding ...

jp-morgan-maintains-overweight-on-insmed-raises-price-target-to-135
JP Morgan Maintains Overweight on Insmed, ...
08/20/2025 14:50:58

JP Morgan analyst Jessica Fye maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $111 to $135.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION